Phase 3 Readout~month

Phase 3 Topline: A Double-blind, Randomized Clinical Trial Evaluating the Efficacy and Safety of Vormatrigine in Adul

Indication
Focal Epilepsy

Other upcoming events for PRAX

PDUFA DatePDUFA Date: relutrigine
PDUFA DatePDUFA Date: relutrigine
Phase 3 ReadoutPhase 3 Topline: Phase 3, Decentralized, Randomized, Double-Blind, Placebo Controlled, Parallel Design, Randomized Wi
PDUFA DatePDUFA Date: relutrigine
PDUFA DatePDUFA Date: ulixacaltamide hcl

Track this catalyst and more

Get real-time alerts, AI-powered analysis, and full catalyst coverage.

Start FreeFull Calendar
    Phase 3 Topline: A Double-blind, Randomized Clinical Trial Evaluating the Efficacy and Safety of Vormatrigine in Adul — PRAX Phase 3 Readout | BioSniper